Lucentis® eye injections work to
treat diabetic macular edema, or swelling of the macula-a leading cause of
vision loss associated with diabetes. “This is really good news for our
diabetic patients who are experiencing diabetic eye problems,” commented
Andreas Wolter, M.D. of Seeta Eye Centers in
Poughkeepsie, Fishkill and Carmel, New York. Lucentis® has been used for
some time to is to treat “wet” age-related macular degeneration (AMD) and now Lucentis®
is the first drug FDA approved to treat diabetic macular edema. More than
500,000 people in the U.S. have diabetic eye disease and before Lucentis® had
to have laser treatment to address this complication of diabetic
retinopathy. “The use of Lucentis® to
treat diabetic macular edema gives us a great tool and a significant advantage
is managing vision loss from diabetes,” commented Dr. Wolter. “As we well know, the key to preservation
of eye health and vision for diabetics is early detection, diagnosis and
treatment.”
If you
or someone you know has questions or needs an eye exam for diabetic eye disease
or the problems from diabetic retinopathy and diabetic retinopathy please
feel free to call
Seeta Eye Centers and schedule an
eye examination by calling 845-454-1025, visiting Seeta Eye Centers or
facebook.com/seetaeyecenters.
Seeta Eye Centersis conveniently located at 23 Davis Avenue Poughkeepsie, New York 12524 and 664 Stoneleigh Avenue, Suite 100, Carmel, New York 10512.
No comments:
Post a Comment